Eliquis Market, By Indication (Reduction of Risk of Stroke and Systemic Embolism in Nonvalvular Atrial Fibrillation , Prophylaxis of Deep Vein Thrombosis Following Hip or Knee Replacement Surgery , Deep Vein Thrombosis , Pulmonary Embolism , Reduction in the Risk of Recurrence of Deep Vein Thrombosis and Pulmonary Embolism , Venous Thromboembolism (VTE) and Reduction in the Risk of Recurrent VTE in Pediatric Patients), By Strength (2.5 mg and 5 mg), By Age Group (Pediatric and Adult), By Dosage Form (Oral Tablet and Oral Suspension), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
Select a License Type that Suits your Business Needs
US$ 2,000
Two thousand dollars
Single User License
( Full Report )
US$ 4,500
US$ 3,000
Three thousand dollars
Frequently purchased
Multi User License
( Full Report )
US$ 7,000
US$ 5,000
Five thousand dollars
Corporate User License
( Full Report )
US$ 10,000
US$ 6000
Six thousand dollars
Client Testimonials
Client Testimonials
Our Clients
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

860519526
9001:2015
27001:2022